About us
LTU School of Cancer Medicine
Our Partners
Our People
Our Corporate Publications
Our Policies
A message from our Founding Champion
Our Research
Research Programs
Genome Engineering and Cancer Modelling Program
Blood Cancer and Immunotherapy Lab
Tumour Environment and Immunology Program
Cancer and Inflammation Laboratory
Tumour Immunology Laboratory
Mucosal Immunity and Cancer Laboratory
Tissue and Tumour Immunity Laboratory
Tumour Microenvironment and Cancer Signaling Group
Cytokine and Cancer Signalling Group
Cancer Biology and Therapy Program
Oncogenic Transcription Laboratory
Metastasis Research Laboratory
Tumour Progression and Heterogeneity Laboratory
Cell Death and Survival Laboratory
Cancer Single Cell Genomics Laboratory
Molecular Immunology Laboratory
Tumour Targeting Program
Tumour Targeting Laboratory
Receptor Biology Laboratory
Centre for Research Excellence in Brain Cancer
Bioinformatics and Cancer Genomics Laboratory
Research Platforms
The ACRF Centre for Translational Cancer Therapeutics and Imaging
The ACRF Centre for Imaging the Tumour Environment
VECTRA Multi-Spectral Imaging Platform
Mammalian Protein Expression Facility
Flow Cytometry Core Facility
Clinical Trials
Latest news
Join our team
Study opportunities
Career opportunities
Volunteer Opportunities
Contact us
Support us
Donate now
Search
Staff
Olivia Newton-John Cancer Research Institute Appoints New CEO
Read More
Learning from low response rates
Read More
Rare cancer models: the key to improving biliary cancer outcomes
Read More
From the laboratory to clinical trial: How one of the ONJCRI’S first honours students is taking on colorectal cancer
Read More
Professor Andrew Scott awarded national grant to target Triple-Negative Breast Cancers
Read More
Dr Ajithkumar Vasanthakumar has been awarded the highly prestigious NHMRC Investigator grant
Read More
New collaboration focuses on cancer prevention, diagnosis and therapy
Read More
MRFF funding awarded to researchers
Read More
Launch of The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine
Read More
Monepantel preclinical investigations to continue with PharmAust
Read More
Privacy Preference Center
Privacy Preferences
